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Atrial fibrillation is present in approximately 50% of all patientsundergoing surgery for the treatment of mitral valve disease.1-3For more than 40 years, cardiac surgeons have been forced toignore this associated atrial fibrillation at the time of open mitralvalve surgery because there has been no effective way to treat it.After the success of the maze procedure in treating atrial fibril-
lation,4-6 several surgeons began to add the maze procedure as an adjunct to mitral
valve surgery to treat both problems.7-9 When properly performed, the results with
this combined approach have been excellent, with no increase in perioperative
morbidity or operative mortality and with documented long-term advantages over
simply leaving patients in atrial fibrillation.8,9 Despite these results, adding the maze
procedure to mitral valve surgery significantly prolongs and complicates the oper-
ation; therefore, most surgeons have understandably been reluctant to perform the
combined procedure.
During the past 2 to 3 years, cardiologists have become extremely aggressive in
their efforts to treat atrial fibrillation by modifications of the percutaneous radio-
frequency catheters that have been so successful in treating other types of arrhyth-
mias, especially the Wolff-Parkinson-White syndrome.10-13 It was only a matter of
time until some surgeons used these same percutaneous endocardial catheters to
treat atrial fibrillation intraoperatively when performing mitral valve surgery. This
new surgical intervention was quickly recognized by medical device companies as
a new market and, as a result, new radiofrequency devices have been adapted
specifically for intraoperative use.
In this issue of the Journal [J Thorac Cardiovasc Surg 2001;122:249-56], the
group from Maastricht, The Netherlands, describes the use of intraoperative radio-
frequency catheters to ablate atrial fibrillation in patients who required surgery
primarily for mitral valve disease. This study is particularly important because it
comes from perhaps the premier electrophysiology group in the world, especially in
the area of atrial fibrillation. Clinical electrophysiology was born in the laboratory
of Professor Dirk Durrer of Amsterdam and led to his becoming the first to perform
an intraoperative electrophysiologic map of the human heart in 1957. In 1967, Dr
Durrer’s brilliant prote´ge´, Professor Hein J. J. Wellens, one of the authors of this
article, described the technique of programmed electrical stimulation that provided
a method for reproducibly inducing and terminating reentrant arrhythmias. This
landmark achievement made possible the systematic characterization of most clin-
ical arrhythmias and has remained largely unchanged since that time. Thus, it
behooves us all to listen when this group speaks of electrophysiology matters!
The authors describe their experience with the use of intraoperative radiofre-
quency catheters to create linear lesions in both atria in an effort to ablate atrial
fibrillation associated with other surgical heart disease in 122 patients, 108 of whom
had associated mitral valve surgery. The pattern of lesions placed in the atria was
described as “a modification of the maze III procedure.” Actuarial freedom from
atrial flutter or atrial fibrillation at 39 months was 78.5%  5.1%.
These results are consistent with those obtained by Melo’s group in Portugal,14
Mohr’s group in Leipzig, Germany,15 and Alfieri’s group in Italy,16 all of whom also
use radiofrequency energy to create the lesions in the atria. Similar results have also
been attained by Stephan Schuler in Dresden, Germany,17 using microwave energy
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to create the atrial lesions. However, these studies raise an
important question. Why are 20% to 30% of the patients not
cured of their atrial fibrillation? Assuming that an 80% cure
rate is not acceptable to most cardiac surgeons, we are
obligated to answer that question.
During the past several years, at least two major obser-
vations regarding atrial fibrillation have had a direct impact
on these new intraoperative techniques to treat atrial fibril-
lation associated with mitral valve disease. The first is that
the maze procedure, when properly performed, cures atrial
fibrillation in nearly 100% of patients with or without mitral
valve disease.4-6 The second is that the majority of parox-
ysmal (intermittent) atrial fibrillation originates within the
orifices of one or more of the pulmonary veins.18 Thus, to
my knowledge, all of the techniques now being used to treat
atrial fibrillation during mitral valve surgery incorporate
some combination of the linear lesions of the maze proce-
dure with isolation of one or more of the pulmonary vein
orifices. Unfortunately, the scientific basis for these various
approaches is somewhat less than completely sound.
A cardinal rule of scientific experimentation is that all
variables in an experiment must be controlled except the
one variable that is being studied. Thus, when attempting to
modify a successful operative procedure, one should avoid
introducing more than one variable if the final results of the
modification are to be subject to scientific interpretation.
Unfortunately, these recent attempts to ablate atrial fibrilla-
tion at the time of mitral valve surgery have violated that
principle, because multiple variables have been introduced
simultaneously, thereby precluding our ability to identify
the reason for the 20% failure rate. For example, the fol-
lowing combinations of variables are currently in the mix of
intraoperative approaches to the treatment of atrial fibrilla-
tion during mitral valve surgery.
1. Different energy sources to create atrial lesions:
These include radiofrequency energy, microwave en-
ergy, laser energy cryosurgery, and the cut-and-sew
technique.
2. Different locations of the atrial lesions: These include
“left-sided mazes,” “right-sided mazes,” pulmonary
vein encirclement only, and the connection of various
pulmonary vein orifices in various combinations with
or without a contiguous lesion down to the mitral
valve anulus, ignoring the importance of the coronary
sinus in postoperative atrial flutter and fibrillation.
Energy Source
The basis of all arrhythmia surgery since Dr Sealy’s first
operation for the Wolff-Parkinson-White syndrome in
196819 is that the fibrocytes that make up scar tissue will not
conduct electricity. Indeed, fibrocytes may well be the most
effective insulators against electrical conduction in all of
nature, since a single cell layer of fibrocytes will block
electrical conduction in the heart permanently. For a line of
complete conduction block to be created, however, a lesion
placed in the atrial wall must be transmural or else electrical
activity can traverse the line of the lesion.20 For example, if
a linear radiofrequency lesion is placed on the endocardial
side of the atrium and is not transmural, electrical activity
can traverse the line of the lesion on its epicardial side.
Conversely, if a linear lesion is placed on the epicardial side
of the atrium and is not transmural, electrical activity can
traverse the line of the lesion on its endocardial side.
When the maze procedure was originally developed, we
chose to use the cut-and-sew technique exclusively for one
simple reason: We could be absolutely certain that each and
every atrial lesion was transmural because we could see that
it was. We then placed a cryolesion at any site where there
might be microscopic connections remaining that could not
be seen and that might allow electrical conduction to
“bridge” the otherwise transmural atrial lesion. These sites
included the ends of two right atriotomies that terminated at
the tricuspid valve anulus, one left atriotomy that terminated
at the mitral valve anulus, and the coronary sinus that itself
bridges one of the posterior left atriotomies. By using this
technique exclusively, we could be certain that if the oper-
ation ultimately failed, it would do so because it was based
on a faulty concept, not because it had been performed
incorrectly or incompletely.
When we had to make the first modification of the maze
procedure (from the maze I to the maze II procedure),21,22
the only variable that was introduced was a slight change in
the precise pattern of the atrial lesions. The basic cut-and-
sew technique was left unchanged. Again, when we made
the second modification (from the maze II to the maze III
procedure),21,22 we still were careful to introduce only one
variable, a change in the pattern of the atriotomies, with the
modification. As a result, the efficacy of the maze procedure
in curing atrial fibrillation remained unchanged from the
maze I to the maze II to the maze III, but the undesirable
side-effects of the first two procedures were eliminated by
these modifications.
The major problem with using radiofrequency, micro-
wave, or laser energy to treat atrial fibrillation is that there
is no way to document with certainty that a lesion is trans-
mural at the time it is created. Studies have been performed
to relate the depth of a lesion to the energy expended, time
of application, and temperature of the probe tip,23-25 but the
fact remains that there is simply no real-time method of
being certain that a given lesion is transmural using these
energy sources.
What, then, are the alternatives to creating the lesions
with the old cut-and-sew technique that allow for real-time
documentation of the transmurality of the linear lesions?
We now use cryosurgery for the creation of these linear
lesions,9 rather than the cut-and-sew technique, because the
surgeon simply has to look at the cryolesion to see when it
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has become transmural. Once the ice ball has become trans-
mural, the cryoprobe is held in place for 120 seconds and
then defrosted. The certainty of permanent transmurality
with this method is based on scientific and clinical studies
dating back over 25 years to when cryosurgery was first
used intraoperatively to treat cardiac arrhythmias.26-28 In
fact, we now perform the entire maze procedure using linear
cryoprobes, rather than the cut-and-sew technique, whether
or not it is performed in combination with mitral valve
surgery.
Pattern of Atrial Lesions
The recent demonstration by Haissaguerre and associates18
that the majority of atrial fibrillation originates within the
pulmonary veins was at once a magnificent revelation for
basic electrophysiologists and a treacherous trap for unsus-
pecting interventional electrophysiologists and arrhythmia
surgeons. This important contribution to the understanding
of atrial fibrillation does not represent the holy grail for
treatment purposes, but rather it is the remaining piece of
the previously incomplete puzzle of atrial fibrillation. It fits
with the other pieces in the following manner.
Under normal circumstances, the atria are activated by
the sinus node, remain in sinus rhythm, and are extremely
resistant to the development of atrial fibrillation, as evi-
denced by the fact that less than 2% of the general popula-
tion is in atrial fibrillation.29 Because there is a transition
zone between the endothelium of the pulmonary veins and
the endocardium of the left atrium, this is the proper milieu
for the development of MICRO-reentry circuits that can
lead to premature atrial beats. These premature atrial beats,
in turn, can stimulate the atria in such a manner that MAC-
RO-reentrant circuits are set up in the atria that become
self-perpetuating. This is atrial fibrillation.30 In other words,
the atrial fibrillation is initiated by micro-reentrant circuits
within the pulmonary veins and is sustained by macro-
reentrant circuits in the atrial myocardium itself.
Usually, the atria retain their natural tendency to remain
in a normal rhythm, so they will eventually spontaneously
revert to a normal sinus rhythm. Later, the micro-reentry
circuits in the pulmonary veins reinduce atrial fibrillation,
and we recognize the clinical picture of paroxysmal (inter-
mittent) atrial fibrillation. This type of atrial fibrillation can
be cured by one of the following techniques:
1. Identifying the culprit pulmonary vein and ablating
the micro-reentrant circuit within its orifice
This is the basis for the percutaneous endocardial
catheter mapping followed by map-guided radiofre-
quency ablation within a single pulmonary vein ori-
fice that is now performed by interventional electro-
physiologists.
2. Identifying the culprit pulmonary vein and isolating
its orifice from the remainder of the atrial myocar-
dium
This also involves catheter mapping by interventional
electrophysiologists but is followed by attempts at
placing circumferential rings of block around the or-
ifice of the culprit pulmonary vein using either radio-
frequency, cryothermia, ultrasound, microwave, or
laser energy sources.
3. Isolating the orifices of all four pulmonary veins from
the remainder of the atrial myocardium
This is the most logical way for surgeons to treat this
type of atrial fibrillation during mitral valve surgery
because there is currently no way of identifying the
culprit pulmonary vein intraoperatively.
Unfortunately, as the atrium begins to fibrillate more and
more, it undergoes a process that has been described as
“atrial remodeling” by Professor Maurits Allessie,31 one of
Professor Wellens’ brilliant colleagues in Maastricht. All-
essie describes the results of this electrophysiologic (and
perhaps anatomic) remodeling as “atrial fibrillation begets
atrial fibrillation.” In other words, the more the atrium
fibrillates, the more it is inclined to fibrillate. Finally, in
most patients, the paroxysmal atrial fibrillation evolves into
chronic (continuous) atrial fibrillation because of this pro-
cess of atrial remodeling.
From the treatment standpoint, it is critical to understand
that once this has occurred, the pulmonary veins, and the
latent or active micro-reentrant circuits that they may har-
bor, become irrelevant to the maintenance of the atrial
fibrillation. In other words, not even complete isolation of
all four pulmonary veins will ablate the atrial fibrillation at
this point, and certainly anything less than their complete
isolation cannot be expected to be effective. Indeed, the
only known nonpharmacologic way to stop the atrial fibril-
lation at this point is to render the atria incapable of har-
boring the macro-reentrant circuits that are the basis of atrial
fibrillation once it is established. This is what the maze
procedure does. Unfortunately, no other pattern of atrial
lesions has yet been described to accomplish this goal.
In summary, the attempts at ablating atrial fibrillation
during mitral valve surgery using multiple energy sources
that are easy to handle and quick to apply is to be strongly
encouraged. However, surgeons should make every effort to
assure that the lesions they create are transmural in every
instance, or else the operation is doomed to a high rate of
failure.20 Furthermore, until a less complex pattern of atrial
lesions has been shown to be as effective as the maze
procedure, I believe that the pattern of lesions applied
during surgery should conform exactly, or nearly so, to the
pattern of the maze procedure. With minor modifications,
the maze procedure can now be performed with the use of
linear cryoprobes to assure transmurality without substan-
tially increasing either the complexity or the duration of
mitral valve surgery and with the expectation that 99% of
the atrial fibrillation associated with the mitral valve disease
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will be cured. That should be the goal of any other energy
source and of any other pattern of atrial lesions.
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